It would be also interesting to synthesize and develop pharmacological compounds that target TRPV1, TRPV2, and TRPA1 that were shown to be downregulated in some types of cancers and whose activity enhances differentiation and impairs stemness. The gene discussed is TRPA1; the disease is cancer.